FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1781 October 25, 2007 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

To the Editor: Medium-chain acyl–coenzyme A dehydrogenase (MCAD) deficiency is the most frequently diagnosed defect in mitochondrial beta-oxidation, with a prevalence of 1 case per 15,000 persons in the United States.¹ Since patients with MCAD deficiency typically present at 3 to 24 months of age with an unanticipated episode of life-threatening, hypoketotic hypoglycemia, the disease has been a prime impetus for the screening of newborns' blood with tandem mass spectroscopy, a major new public health initiative.

We report on a 3-day-old neonate with lethargy, ketotic hypoglycemia, and poor feeding; incessant ventricular tachyarrhythmia developed, which progressed to episodes of torsades de . . . [Full Text of this Article]

Related Letters:

More on Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in a Neonate
Wilcken B., Hoffman G., Rice G., Wolff J. A.
Extract | Full Text | PDF  
N Engl J Med 2008; 358:647, Feb 7, 2008. Correspondence

This article has been cited by other articles:

• Wilcken, B., Hoffman, G., Rice, G., Wolff, J. A. (2008). More on Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in a Neonate. NEJM 358: 647-647 [Full Text]